Media Outlets Report On Efforts To Develop Novel Coronavirus Treatments, Vaccines

The Atlantic: The Best Hopes for a Coronavirus Drug (Zhang, 4/8).

Financial Times: Covid-19 drugs could be made for $1 per day, say academics (Mancini, 4/9).

The Lancet: Regulators split on antimalarials for COVID-19 (Jaffe, 4/11).

Nature: If a coronavirus vaccine arrives, can the world make enough? (Khamsi, 4/9).

New York Times: At the Center of a Storm: the Search for a Proven Coronavirus Treatment (Kolata, 4/9).

Quartz: A ‘bridge to a vaccine’: The race to roll out antibody-based Covid-19 drugs (McDonnell, 4/8).

Reuters: Key China coronavirus hospital says HIV drug beneficial to patients (Goh et al., 4/9).

Science: Can prophylactic drugs keep fragile health systems running? (Kupferschmidt, 4/10).

Science: Is France’s president fueling the hype over an unproven coronavirus treatment? (Sciama, 4/9).

VOA: China Recruits Volunteers for Phase 2 Coronavirus Vaccine Trial (Xie, 4/9).

Wall Street Journal: The Bats Behind the Pandemic (Ridley, 4/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.